Ossó, Júlia Lacombe
Glemain, Benjamin
Dorival, Céline
Blanché, Hélène
Lemogne, Cédric
Deleuze, Jean-François
Robineau, Olivier
Touvier, Mathilde
Severi, Gianluca
Zins, Marie
,
Lusivika-Nzinga, Clovis
Pannetier, Gregory
Lapidus, Nathanael
Goderel, Isabelle
Nicol, Jérôme
Kab, Sofiane
Renuy, Adeline
Le-Got, Stephane
Ribet, Celine
Wiernik, Emmanuel
Goldberg, Marcel
Artaud, Fanny
Gerbouin-Rérolle, Pascale
Enguix, Mélody
Laplanche, Camille
Gomes-Rima, Roselyn
Hoang, Lyan
Correia, Emmanuelle
Barry, Alpha Amadou
Senina, Nadège
Allegre, Julien
de Edelenyi, Fabien Szabo
Druesne-Pecollo, Nathalie
Esseddik, Younes
Hercberg, Serge
Deschasaux, Mélanie
Sébaoun, Jean-Marc
Beaudoin, Jean-Christophe
Gressin, Laetitia
Morel, Valérie
Ouili, Ouissam
Ninove, Laetitia
Priet, Stéphane
Villarroel, Paola Mariela Saba
Fourié, Toscane
Ali, Souand Mohamed
Amroun, Abdenour
Seston, Morgan
Ayhan, Nazli
Pastorino, Boris
de Lamballerie, Xavier
Carrat, Fabrice
Article History
Received: 26 May 2025
Accepted: 3 October 2025
First Online: 1 December 2025
Declarations
:
: Ethical approval and written or electronic informed consent were obtained from each participant before enrolment in the original cohort. The SAPRIS-SERO study was approved by the Sud-Mediterranée III ethics committee (approval #20.04.22.74247) and electronic informed consent was obtained from all participants for DBS testing. The study was registered (#NCT04392388). The study was conducted in accordance with the ethical principles of the Declaration of Helsinki ( ).
: Not applicable.
: The authors declare no competing interests.